Tarosin, 20 tablets, Zentiva

Tablets containing rutozide 20 mg; ascorbic acid 50 mg.

Pharmacotherapeutic action:

• Rutoside (biflavonoid) acts at the capillary level, improving their functionality by reducing abnormal interstitial diffusion and increasing resistance
• Ascorbic acid is involved in the stimulation of cellular respiration and in the synthesis of collagen and fundamental substance in the interstitial tissue, reducing the risk of hemorrhages by reducing capillary fragility
• Both substances have chelating properties
• Rutoside protects ascorbic acid from oxidation, the two components potentiating each other's effects
• Tarosin is well absorbed from the digestive tract, being eliminated through the kidneys.

Indications:

• Conditions accompanied by capillary fragility or an abnormal permeability of their walls: endogenous or toxic vascular purpura (intoxication with gold salts, barbiturates, salicylates), retinal, digestive, renal hemorrhages, etc.
• Allergic conditions, hemoptysis, infectious diseases with capillary damage (scarlet fever, exanthematic typhus, etc.), varicose veins, hemorrhoids.

Composition:

Rutoside 20 mg; ascorbic acid 50 mg.

How to use:

• Tarosin is administered without food, with very little water, in doses every 2-3 hours
• Adults: 1 - 3 tablets per day.

Storage conditions:

Protect from light, heat and moisture.

Presentation: 20 tablets